StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Potassium Iodide → (6R,7R)-3-[[5-amino-4-[[2-(2-aminoethylamino)-2-oxoacetyl]amino]-1-methylpyrazol-2-ium-2-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

HRID 1247818
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1247818
[NH2:1][C:2]1[S:6][N:5]=[C:4](/[C:7](=[N:34]/[O:35][C:36]([C:39]([O:41]C(C)(C)C)=[O:40])([CH3:38])[CH3:37])/[C:8]([NH:10][C@@H:11]2[C:32](=[O:33])[N:13]3[C:14]([C:20]([O:22]CC4C=CC(OC)=CC=4)=[O:21])=[C:15]([CH2:18]Cl)[CH2:16][S:17][C@H:12]23)=[O:9])[N:3]=1.C[Si](C)(C)NC(=O)C.[I-].[K+].[CH3:56][N:57]1[C:61]([NH:62]C(C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=[C:60]([NH:82][C:83](=[O:97])[C:84]([NH:86][CH2:87][CH2:88][NH:89]C(=O)OC(C)(C)C)=[O:85])[CH:59]=[N:58]1>CN(C)C=O.C(OCC)(=O)C>[NH2:62][C:61]1[N:57]([CH3:56])[N+:58]([CH2:18][C:15]2[CH2:16][S:17][C@@H:12]3[C@H:11]([NH:10][C:8](=[O:9])/[C:7](/[C:4]4[N:3]=[C:2]([NH2:1])[S:6][N:5]=4)=[N:34]\[O:35][C:36]([C:39]([OH:41])=[O:40])([CH3:38])[CH3:37])[C:32](=[O:33])[N:13]3[C:14]=2[C:20]([O-:22])=[O:21])=[CH:59][C:60]=1[NH:82][C:83](=[O:97])[C:84]([NH:86][CH2:87][CH2:88][NH2:89])=[O:85]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

7

Edukt 4

HCID 4875Potassium IodideHCID 25989Acetamide, N-(trimethylsilyl)-HCID 86593408tert-butyl {2-[(2-{[1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]amino)-2-oxoacetyl)amino]ethyl}carbamateHCID 87481325Ceftolozane Impurity 20

Produkt 1

HCID 141604716
(6R,7R)-3-[[5-amino-4-[[2-(2-aminoethylamino)-2-oxoacetyl]amino]-1-methylpyrazol-2-ium-2-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Ausbeute 4,9 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 6228DimethylformamideLösungsmittel2×HCID 8857Ethyl AcetateLösungsmittel

Versuchsvorschrift

To a solution of 4-methoxybenzyl 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-tert-butoxycarbonyl-1-methylethoxyimino)acetamido]-3-chloromethyl-3-cephem-4-carboxylate (618 mg) in N,N-dimethylformamide (1.5 ml) was added N-(trimethylsilyl)acetamide (656 mg), and the mixture was stirred at room temperature for 40 minutes. To the solution was added potassium iodide (232 mg), and the mixture was stirred at room temperature for 35 minutes. To the reaction mixture was added a solution of tert-butyl {2-[(2-{[1-methyl-5-(tritylamino)-1H-pyrazol-4-yl]amino}-2-oxoacetyl)amino]ethyl}carbamate (626 mg) in N,N-dimethylformamide (3 ml), and the whole mixture was stirred at 35–40° C. for 24 hours. To the resulting reaction mixture was added ethyl acetate (50 ml), and the solution was washed successively with water (50 ml×2), 10% aqueous sodium trifluoroacetate solution (50 ml×2), and brine (50 ml), dried over anhydrous sodium sulfate and filtered. The filtrate was concentrated to about 10 ml in vacuo. The concentrate was poured into diisopropyl ether (60 ml), and the resulting precipitate was collected by filtration and dried in vacuo. To a solution of the solid in methylene chloride (2.9 ml) were added anisole (0.95 ml) and trifluoroacetic acid (2.9 ml). The resulting solution was stirred at room temperature for 4 hours and poured into diisopropyl ether (60 ml). The resulting precipitate was collected by filtration and dried in vacuo to give a crude product (770 mg), which was purified by preparative HPLC utilizing ODS column. The eluate containing a desired product was concentrated to about 30 ml in vacuo. The concentrate was adjusted to about pH 3 with concentrated hydrochloric acid and chromatographed on Diaion® HP-20 (Mitsubishi Chemical Corporation) eluting with 30% aqueous 2-propanol. The eluate was concentrated to about 10 ml in vacuo and lyophilized to give 3-{[3-amino-4-({2-[(2-aminoethyl)amino]-2-oxoacetyl}amino)-2-methyl-1-pyrazolio]methyl}-7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido]-3-cephem-4-carboxylate (31 mg) as an amorphous solid.

Aufarbeitung

  1. stirringthe mixture was stirred at room temperature for 35 minutes
  2. stirringthe whole mixture was stirred at 35–40° C. for 24 hours
  3. customTo the resulting reaction mixture
  4. washthe solution was washed successively with water (50 ml×2), 10% aqueous sodium trifluoroacetate solution (50 ml×2), and brine (50 ml)
  5. dry with materialdried over anhydrous sodium sulfate
  6. filtrationfiltered
  7. concentrationThe filtrate was concentrated to about 10 ml in vacuo
  8. additionThe concentrate was poured into diisopropyl ether (60 ml)
  9. filtrationthe resulting precipitate was collected by filtration
  10. customdried in vacuo
  11. additionTo a solution of the solid in methylene chloride (2.9 ml) were added anisole (0.95 ml) and trifluoroacetic acid (2.9 ml)
  12. stirringThe resulting solution was stirred at room temperature for 4 hours
  13. additionpoured into diisopropyl ether (60 ml)
  14. filtrationThe resulting precipitate was collected by filtration
  15. customdried in vacuo
  16. customto give a crude product (770 mg), which
  17. customwas purified by preparative HPLC
  18. additionThe eluate containing a desired product
  19. concentrationwas concentrated to about 30 ml in vacuo
  20. customchromatographed on Diaion®
  21. wash(Mitsubishi Chemical Corporation) eluting with 30% aqueous 2-propanol
  22. concentrationThe eluate was concentrated to about 10 ml in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-c6c95b83f6e34c3887c343c7ec2b77f0
Quelldatensatz
uspto-grants-2006_10
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US07129232B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion